Closing of acquisitions on track to deliver value of US$48m/AU$66m PV10 vs current market cap of AU$11m... DYOR GLTAH
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%